Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation

American Journal of Transplantation

Volumn 14, Issue 9, 2014, Pages 2023-2036

  Treacy, O ^a   O'Flynn, L ^a   Ryan, A E ^a   Morcos, M ^a   Lohan, P ^a   Schu, S ^a   Wilk, M ^a   Fahy, G ^b   Griffin, M D ^a   Nosov, M ^a,c   Ritter, T ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c FarmLab Diagnostics Emlagh Elphin Co   (Ireland)

Author keywords

Basic (laboratory) research science; corneal transplantation ophthalmology; immune regulation; immunosuppression immune modulation; regenerative medicine; stem cells; translational research science

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; CD161 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; IMMUNOLOGICAL ADJUVANT; PRIMER DNA;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CORNEA TRANSPLANTATION; DELAYED HYPERSENSITIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; LEWIS RAT; LOCAL IMMUNOMODULATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NATURAL KILLER T CELL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; SYSTEMIC IMMUNOMODULATION; ALLOTRANSPLANTATION; ANIMAL; CORNEAL DISEASES; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BASE SEQUENCE; CORNEAL DISEASES; DNA PRIMERS; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84906214083     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12828     Document Type: Article

References (43)

1. Ritter T, Pleyer U., Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation. Expert Rev Clin Immunol 2009; 5: 749-764.
2. Streilein JW., Immunobiology and immunopathology of corneal transplantation. Chem Immunol 1999; 73: 186-206.
3. George AJ, Larkin DF., Corneal transplantation: The forgotten graft. Am J Transplant 2004; 4: 678-685.
4. Coster DJ, Williams KA., The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 2005; 140: 1112-1122.
5. Williams KA, Coster DJ., The immunobiology of corneal transplantation. Transplantation 2007; 84: 806-813.
6. Niederkorn JY, Larkin DF., Immune privilege of corneal allografts. Ocul Immunol Inflamm 2010; 18: 162-171.
7. Niederkorn JY., Cornea: Window to ocular immunology. Curr Immunol Rev 2012; 7: 328-335.
8. Barry FP, Murphy JM., Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36: 568-584.
9. Krampera M, Pizzolo G, Aprili G, Franchini M., Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 2006; 39: 678-683.
10. Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T., Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: What have we learned so far ? Immunol Cell Biol 2013; 91: 40-51.
11. Griffin MD, Ritter T, Mahon B., Immunological aspects of allogeneic mesenchymal stem cell therapy. Hum Gene Ther 2010; 21: 1641-1655.
12. Ankrum J, Karp JM., Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med 2010; 16: 203-209.
13. Caplan AI., Why are MSCs therapeutic? New data: New insight. J Pathol 2009; 217: 318-324.
14. Dazzi F, Lopes L, Weng L., Mesenchymal stromal cells: A key player in 'innate tolerance' ? Immunology 2012; 137: 206-213.
15. Nauta AJ, Fibbe WE., Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-3506.
16. Prockop DJ, Oh JY., Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012; 20: 14-20.
17. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
18. Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-49.
19. English K, French A, Wood KJ., Mesenchymal stromal cells: Facilitators of successful transplantation ? Cell Stem Cell 2010; 7: 431-442.
20. Oh JY, Kim MK, Shin MS, et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 2008; 26: 1047-1055.
21. Reinshagen H, Auw-Haedrich C, Sorg RV, et al. Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits. Acta Ophthalmol 2009; 89: 741-748.
22. Oh JY, Lee RH, Yu JM, et al. Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther 2012; 20: 2143-2152.
23. Nosov M, Wilk M, Morcos M, et al. Role of lentivirus-mediated overexpression of programmed death-ligand 1 on corneal allograft survival. Am J Transplant 2012; 12: 1313-1322.
24. Schu S, Nosov M, O'Flynn L, et al. Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 2012; 16: 2094-2103.
25. Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-150.
26. Ren G, Su J, Zhang L, et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27: 1954-1962.
27. Ren G, Zhao X, Zhang L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010; 184: 2321-2328.
28. Duijvestein M, Wildenberg ME, Welling MM, et al. Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 2011; 29: 1549-1558.
29. François M, Romieu-Mourez R, Li M, Galipeau J., Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 2012; 20: 187-195.
30. Li W, Ren G, Huang Y, et al. Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ 2012; 19: 1505-1513.
31. Chauhan SK, Saban DR, Lee HK, Dana R., Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 2009; 182: 148-153.
32. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA., CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
33. Clarke SL, Betts GJ, Plant A, et al. CD4+CD25+Foxp3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE 2006; 1: e129.
34. Casiraghi F, Azzollini N, Cassis P, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933-3946.
35. Casiraghi F, Azzollini N, Todeschini M, et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant 2012; 12: 2373-2383.
36. Ye J, Kao K, Kim JC., Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: Engraftment and involvement in wound healing. Eye 2006; 20: 482-490.
37. Ma Y, Xu Y, Xiao Z, et al. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells 2006; 24: 315-321.
38. Ye J, Lee SY, Kook KH, Yao K., Bone marrow-derived progenitor cells promote corneal wound healing following alkali injury. Graefes Arch Clin Exp Ophthalmol 2008; 246: 217-222.
39. Jia Z, Jiao C, Zhao S, et al. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Exp Eye Res 2012; 102: 44-49.
40. Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G., How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012; 33: 136-143.
41. Bernardo ME, Fibbe WE., Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 2013; 13: 392-402.
42. O'Flynn L, Treacy O, Ryan AE, et al. Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu. Mol Ther 2013; 21: 2102-2112.
43. Hegde S, Mellon JK, Hargrave SL, Niederkorn JY., Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci 2002; 43: 1012-1018.